Cargando…

The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule

CD8+ T cells are crucial for anti-viral immunity; however, understanding T cell responses requires the identification of epitopes presented by human leukocyte antigens (HLA). To date, few SARS-CoV-2-specific CD8+ T cell epitopes have been described. Internal viral proteins are typically more conserv...

Descripción completa

Detalles Bibliográficos
Autores principales: Szeto, Christopher, Chatzileontiadou, Demetra S.M., Nguyen, Andrea T., Sloane, Hannah, Lobos, Christian A., Jayasinghe, Dhilshan, Halim, Hanim, Smith, Corey, Riboldi-Tunnicliffe, Alan, Grant, Emma J., Gras, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825995/
https://www.ncbi.nlm.nih.gov/pubmed/33521593
http://dx.doi.org/10.1016/j.isci.2021.102096
_version_ 1783640436756185088
author Szeto, Christopher
Chatzileontiadou, Demetra S.M.
Nguyen, Andrea T.
Sloane, Hannah
Lobos, Christian A.
Jayasinghe, Dhilshan
Halim, Hanim
Smith, Corey
Riboldi-Tunnicliffe, Alan
Grant, Emma J.
Gras, Stephanie
author_facet Szeto, Christopher
Chatzileontiadou, Demetra S.M.
Nguyen, Andrea T.
Sloane, Hannah
Lobos, Christian A.
Jayasinghe, Dhilshan
Halim, Hanim
Smith, Corey
Riboldi-Tunnicliffe, Alan
Grant, Emma J.
Gras, Stephanie
author_sort Szeto, Christopher
collection PubMed
description CD8+ T cells are crucial for anti-viral immunity; however, understanding T cell responses requires the identification of epitopes presented by human leukocyte antigens (HLA). To date, few SARS-CoV-2-specific CD8+ T cell epitopes have been described. Internal viral proteins are typically more conserved than surface proteins and are often the target of CD8+ T cells. Therefore, we have characterized eight peptides derived from the internal SARS-CoV-2 nucleocapsid protein predicted to bind HLA-A(∗)02:01, the most common HLA molecule in the global population. We determined not all peptides could form a complex with HLA-A(∗)02:01, and the six crystal structures determined revealed that some peptides adopted a mobile conformation. We therefore provide a molecular understanding of SARS-CoV-2 CD8+ T cell epitopes. Furthermore, we show that there is limited pre-existing CD8+ T cell response toward these epitopes in unexposed individuals. Together, these data show that SARS-CoV-2 nucleocapsid might not contain potent epitopes restricted to HLA-A(∗)02:01.
format Online
Article
Text
id pubmed-7825995
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-78259952021-01-25 The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule Szeto, Christopher Chatzileontiadou, Demetra S.M. Nguyen, Andrea T. Sloane, Hannah Lobos, Christian A. Jayasinghe, Dhilshan Halim, Hanim Smith, Corey Riboldi-Tunnicliffe, Alan Grant, Emma J. Gras, Stephanie iScience Article CD8+ T cells are crucial for anti-viral immunity; however, understanding T cell responses requires the identification of epitopes presented by human leukocyte antigens (HLA). To date, few SARS-CoV-2-specific CD8+ T cell epitopes have been described. Internal viral proteins are typically more conserved than surface proteins and are often the target of CD8+ T cells. Therefore, we have characterized eight peptides derived from the internal SARS-CoV-2 nucleocapsid protein predicted to bind HLA-A(∗)02:01, the most common HLA molecule in the global population. We determined not all peptides could form a complex with HLA-A(∗)02:01, and the six crystal structures determined revealed that some peptides adopted a mobile conformation. We therefore provide a molecular understanding of SARS-CoV-2 CD8+ T cell epitopes. Furthermore, we show that there is limited pre-existing CD8+ T cell response toward these epitopes in unexposed individuals. Together, these data show that SARS-CoV-2 nucleocapsid might not contain potent epitopes restricted to HLA-A(∗)02:01. Elsevier 2021-01-22 /pmc/articles/PMC7825995/ /pubmed/33521593 http://dx.doi.org/10.1016/j.isci.2021.102096 Text en © 2021 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Szeto, Christopher
Chatzileontiadou, Demetra S.M.
Nguyen, Andrea T.
Sloane, Hannah
Lobos, Christian A.
Jayasinghe, Dhilshan
Halim, Hanim
Smith, Corey
Riboldi-Tunnicliffe, Alan
Grant, Emma J.
Gras, Stephanie
The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule
title The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule
title_full The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule
title_fullStr The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule
title_full_unstemmed The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule
title_short The presentation of SARS-CoV-2 peptides by the common HLA-A(∗)02:01 molecule
title_sort presentation of sars-cov-2 peptides by the common hla-a(∗)02:01 molecule
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825995/
https://www.ncbi.nlm.nih.gov/pubmed/33521593
http://dx.doi.org/10.1016/j.isci.2021.102096
work_keys_str_mv AT szetochristopher thepresentationofsarscov2peptidesbythecommonhlaa0201molecule
AT chatzileontiadoudemetrasm thepresentationofsarscov2peptidesbythecommonhlaa0201molecule
AT nguyenandreat thepresentationofsarscov2peptidesbythecommonhlaa0201molecule
AT sloanehannah thepresentationofsarscov2peptidesbythecommonhlaa0201molecule
AT loboschristiana thepresentationofsarscov2peptidesbythecommonhlaa0201molecule
AT jayasinghedhilshan thepresentationofsarscov2peptidesbythecommonhlaa0201molecule
AT halimhanim thepresentationofsarscov2peptidesbythecommonhlaa0201molecule
AT smithcorey thepresentationofsarscov2peptidesbythecommonhlaa0201molecule
AT ribolditunnicliffealan thepresentationofsarscov2peptidesbythecommonhlaa0201molecule
AT grantemmaj thepresentationofsarscov2peptidesbythecommonhlaa0201molecule
AT grasstephanie thepresentationofsarscov2peptidesbythecommonhlaa0201molecule
AT szetochristopher presentationofsarscov2peptidesbythecommonhlaa0201molecule
AT chatzileontiadoudemetrasm presentationofsarscov2peptidesbythecommonhlaa0201molecule
AT nguyenandreat presentationofsarscov2peptidesbythecommonhlaa0201molecule
AT sloanehannah presentationofsarscov2peptidesbythecommonhlaa0201molecule
AT loboschristiana presentationofsarscov2peptidesbythecommonhlaa0201molecule
AT jayasinghedhilshan presentationofsarscov2peptidesbythecommonhlaa0201molecule
AT halimhanim presentationofsarscov2peptidesbythecommonhlaa0201molecule
AT smithcorey presentationofsarscov2peptidesbythecommonhlaa0201molecule
AT ribolditunnicliffealan presentationofsarscov2peptidesbythecommonhlaa0201molecule
AT grantemmaj presentationofsarscov2peptidesbythecommonhlaa0201molecule
AT grasstephanie presentationofsarscov2peptidesbythecommonhlaa0201molecule